drugset / Trial / NCT05327361
LiftActiv B3 in Post Inflammatory Hyperpigmentation (PIHP)
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this research study is to measure the depigmenting effect of a serum product called Liftactiv B3 in patients with mild to moderate facial PIHP (Post Inflammatory Hyper Pigmentation)
Timeline
- Start
- 2022-03-22
- Primary completion
- 2023-01-17
- Completion
- 2023-03-06
Outcome
Outcome not reported
Stopped (Enrollment): “Enrollment timeline ended”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Liftactiv B3 | Unknown | — | Topical |